Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Pharmacotherapy
|
September 29, 2011
Efficacy, safety, and cost of thrombolytic agents for the management of dysfunctional hemodialysis catheters: a systematic review
Daniel Hilleman, Jennifer Campbell
Seminars in Thrombosis and Hemostasis
|
July 16, 2010
Recombinant peptides in thrombolysis
Jennifer Campbell, Daniel Hilleman
Pharmacotherapy
|
May 2, 2008
Effectiveness of a fenofibrate 145-mg nanoparticle tablet formulation compared with the standard 160-mg tablet in patients with coronary heart disease and dyslipidemia
Stephanie Maciejewski, Daniel Hilleman
Managed Care (Langhorne, Pa.)
|
February 18, 2016
Prescription Omega-3 Fatty Acid Products and Dietary Supplements Are Not Interchangeable
Daniel Hilleman, Aiman Smer
Journal of Asthma and Allergy
|
March 26, 2011
Current trends in the treatment of asthma: focus on the simultaneous administration of salmeterol/fluticasone
Robyn Teply, Jennifer Campbell, Daniel Hilleman
Cardiology Research
|
March 30, 2017
A Review of Currently Available Fenofibrate and Fenofibric Acid Formulations
Hua Ling, John T Luoma, Daniel Hilleman
Lipids in Health and Disease
|
July 23, 2016
The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia
James Backes, Deborah Anzalone, Daniel Hilleman, et al.
Pharmacotherapy
|
April 7, 2022
Statin-associated muscle symptoms-A review: Individualizing the approach to optimize care
Barbara S Wiggins, James M Backes, Daniel Hilleman
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
October 5, 2021
Management of patients with fibrosing interstitial lung diseases
Lee E Morrow, Daniel Hilleman, Mark A Malesker
Clinical Therapeutics
|
September 28, 2023
Atherosclerotic Cardiovascular Disease in Women: Providing Protection With Lipid-altering Agents
Megan Hiles, Ashley Simmons, Daniel Hilleman, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Pharmacotherapy
|
September 29, 2011
Efficacy, safety, and cost of thrombolytic agents for the management of dysfunctional hemodialysis catheters: a systematic review
Daniel Hilleman, Jennifer Campbell
Seminars in Thrombosis and Hemostasis
|
July 16, 2010
Recombinant peptides in thrombolysis
Jennifer Campbell, Daniel Hilleman
Pharmacotherapy
|
May 2, 2008
Effectiveness of a fenofibrate 145-mg nanoparticle tablet formulation compared with the standard 160-mg tablet in patients with coronary heart disease and dyslipidemia
Stephanie Maciejewski, Daniel Hilleman
Managed Care (Langhorne, Pa.)
|
February 18, 2016
Prescription Omega-3 Fatty Acid Products and Dietary Supplements Are Not Interchangeable
Daniel Hilleman, Aiman Smer
Journal of Asthma and Allergy
|
March 26, 2011
Current trends in the treatment of asthma: focus on the simultaneous administration of salmeterol/fluticasone
Robyn Teply, Jennifer Campbell, Daniel Hilleman
Cardiology Research
|
March 30, 2017
A Review of Currently Available Fenofibrate and Fenofibric Acid Formulations
Hua Ling, John T Luoma, Daniel Hilleman
Lipids in Health and Disease
|
July 23, 2016
The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia
James Backes, Deborah Anzalone, Daniel Hilleman, et al.
Pharmacotherapy
|
April 7, 2022
Statin-associated muscle symptoms-A review: Individualizing the approach to optimize care
Barbara S Wiggins, James M Backes, Daniel Hilleman
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
October 5, 2021
Management of patients with fibrosing interstitial lung diseases
Lee E Morrow, Daniel Hilleman, Mark A Malesker
Clinical Therapeutics
|
September 28, 2023
Atherosclerotic Cardiovascular Disease in Women: Providing Protection With Lipid-altering Agents
Megan Hiles, Ashley Simmons, Daniel Hilleman, et al.
Page
of 2